Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Alexion Japan Wants to Extend 2-Digit Growth, Ride on Reform Boon: Next Chief
November 15, 2024
- EMA Backs Leqembi after Re-Examination, but for Limited Use
November 15, 2024
- Stella Pharma Ties Up with TLS for Borofalan in US, Europe
November 15, 2024
- MSD Files PAH Treatment Sotatercept in Japan
November 15, 2024
- Keytruda Maintains Top-Selling Title in Japan in July-September: IQVIA
November 14, 2024
- Mitsubishi Chemical Looking for “Best Partners” for Pharma Biz: CEO
November 14, 2024
- Lilly Japan Halts Manufacturing of Strattera over Nitrosamine Impurities
November 14, 2024
- Nippon Shinyaku Bags Japan, US Rights to Atsena’s Gene Therapy
November 14, 2024
- Daiichi Sankyo Replaces FDA Lung Cancer Filing for TROP2-Directed ADC
November 13, 2024
- Pfizer’s Antibiotic Zavicefta Now Available in Japan
November 13, 2024
- Terumo Rolls Out Anapeine Generics after Expedited Listing
November 13, 2024
- Moderna Sees CMV, EBV Vaccines as “Significant Assets”: Medical Affairs Chief
November 12, 2024
- Amvuttra Filed for ATTR-CM in Japan: Alnylam
November 12, 2024
- Japan Ethical Drug Sales Down 0.4% in September: Crecon
November 12, 2024
- Vectibix Plus Lumakras Filed for Colorectal Cancer in Japan
November 11, 2024
- Eisai Cuts Leqembi Sales Target as It Sees “Some Delays” in US Uptake
November 11, 2024
- Lilly’s Pediatric Development Efforts Bore Fruit This Year: Japan CMO
November 8, 2024
- Santen Bags Commercial Rights to Uveitic Macular Edema Drug in China
November 8, 2024
- Keytruda Grabs Top-Selling Crown for 13th Month in October: Encise
November 8, 2024
- UCB to End Cimzia Partnership with Astellas in Japan
November 7, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…